Evolutionary Genomics, Inc. and Eg I, Llc Reports Earnings Results for the Third Quarter Ended September 30, 2019
October 17, 2019 at 10:37 pm IST
Share
Evolutionary Genomics, Inc. And EG I, LLC announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating loss was USD 162,511 compared to USD 144,635 a year ago. Net loss was USD 156,321 compared to USD 265,299 a year ago. Basic loss per share was USD 0.04 compared to USD 0.06 a year ago. For the nine months, operating loss was USD 546,189 compared to USD 659,647 a year ago. Net loss was USD 538,463 compared to USD 913,411 a year ago. Basic loss per share was USD 0.13 compared to USD 0.19 a year ago.
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. It uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The Company uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.
EVOLUTIONARY GENOMICS, INC. 
